BAFN vs EXAS · rev $33.8M vs rev $2.76B
Bayfirst Financial Corp (BAFN) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Bayfirst Financial Corp (BAFN) is a banks - regional company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported BAFN revenue for 2026-06-30 was $33.8M. Net income was -$38.6M. Revenue was up 93.8% from 2026-03-31 to 2026-06-30. BAFN currently screens at market cap $32.7M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
BAFN currently screens at market cap $32.7M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the BAFN and EXAS stock pages for the full models.
Not investment advice.